Peptide Profile

SS-31 // Mitochondrial Shield

Also known as: Also known as: Elamipretide · Bendavia · MTP-131

A cell-permeable tetrapeptide that concentrates 5,000x in the inner mitochondrial membrane, binding cardiolipin to optimize electron transport chain efficiency and reduce reactive oxygen species production. Currently in Phase 3 clinical trials for heart failure. The most advanced mitochondrial-targeted compound in clinical development.

Longevity / Mitochondrial Subcutaneous Injection Phase 3 — Investigational
5000x
Mito Concentration
Phase 3
Clinical Trial
ETC
Efficiency Target
Clinical Development Pipeline
Preclinical
Phase 1
Phase 2
Phase 3
FDA Review
Approved
Quick Reference
Key protocol parameters
Category
Mitochondrial PeptideCardiolipin binding
Route
Subcutaneous
Frequency
Daily
Half-Life
~4 hoursPlasma
Dose Range
40mg/dayPhase 3 dose
Cycle
8–12+ weeksContinuous
Mol. Weight
640.8 DaTetrapeptide
Purity
≥98% HPLCClinical grade available
Reconstitution
20mg + 1mL BAC= 20mg/mL

Repairing the cell's power plant.

Mitochondria produce 90% of your cellular energy. With age, the inner mitochondrial membrane deteriorates — cardiolipin becomes oxidized, electron transport chain efficiency drops, and ROS production increases. SS-31 reverses this decline at the membrane level.

Cardiolipin Binding
SS-31 selectively binds cardiolipin in the inner mitochondrial membrane. This stabilizes the cristae structure and optimizes the interaction between electron transport chain complexes, restoring youthful ATP production efficiency.
ROS Reduction
By optimizing electron flow through the ETC, SS-31 reduces electron leakage that generates reactive oxygen species. Less mitochondrial ROS means less oxidative damage to DNA, proteins, and lipids.
5,000x Concentration
The Szeto-Schiller peptide motif enables SS-31 to cross cell membranes and concentrate 5,000-fold in the inner mitochondrial membrane. This extreme targeting efficiency is unmatched by any other mitochondrial compound.

Daily dosing, continuous protocol.

SS-31 uses continuous daily dosing — the mitochondrial membrane protection is maintained through sustained peptide presence. The Phase 3 clinical trial dose of 40mg/day subcutaneous is the reference standard.

Week 1 · Introduction
20mg/day SubQ
Start at half dose to assess tolerance.
Weeks 2–4 · Ramp
40mg/day SubQ
Phase 3 clinical trial dose.
Weeks 5–12 · Maintenance
40mg/day SubQ
Full protocol duration. Monitor cardiac and metabolic markers.
Post-Cycle · Assessment
Taper or continue
Reassess based on biomarkers and clinical indication.
⚠ Important: SS-31 (Elamipretide) is an investigational compound in Phase 3 clinical trials. It is not FDA-approved. All dosing information is derived from published clinical trial data. This is educational content — not medical advice.

From Szeto-Schiller to Phase 3.

SS-31 was developed by Hazel Szeto and Peter Bhatt at Weill Cornell Medicine. The Szeto-Schiller peptide motif — an alternating aromatic-cationic structure — enables cell membrane penetration and extreme mitochondrial concentration without requiring a targeting sequence.

Preclinical data demonstrated that SS-31 restored mitochondrial function in aged tissues, improved cardiac ejection fraction, reduced ischemia-reperfusion injury, and enhanced skeletal muscle performance. The compound acts by stabilizing cardiolipin-dependent cristae structure.

Phase 2 trials in heart failure with preserved ejection fraction (HFpEF) and Barth syndrome showed improvements in cardiac function markers. Phase 3 trials are ongoing. Additional investigations include primary mitochondrial myopathy, age-related macular degeneration, and renal injury.

Mitochondrial compounds compared.

CompoundTargetMechanismRouteStage
SS-31Inner Mito MembraneCardiolipin BindingSubQ dailyPhase 3
MOTS-CAMPK / NucleusMetabolic SignalingSubQ 3–5x/weekResearch
CoQ10Complex IIIElectron CarrierOral dailySupplement
MitoQMitochondrial MatrixAntioxidantOral dailySupplement

What to watch for.

SS-31's side effect profile is manageable with proper protocol adherence. Baseline blood work before starting and periodic monitoring during use is essential.

Side Effects
  • Injection site reactions (most common in trials)
  • Headache (mild, comparable to placebo in some trials)
  • Nausea (uncommon)
  • Generally well tolerated in Phase 2/3 data
  • No significant safety signals at clinical doses
  • Cardiac monitoring recommended (compound targets heart mitochondria)
Blood Work Panel
  • Cardiac biomarkers (BNP/NT-proBNP, troponin)
  • Echocardiogram (ejection fraction — if cardiac indication)
  • Lactate (mitochondrial function marker)
  • CoQ10 levels
  • Comprehensive metabolic panel
  • Complete blood count
  • hsCRP (inflammation)
  • Creatine kinase (muscle mitochondrial marker)
Stacking Notes
  • MOTS-C for comprehensive mitochondrial longevity (Anti-Aging Stack)
  • Epithalon for telomere + mitochondrial dual targeting
  • NAD+/NMN for NAD+ restoration alongside ETC optimization
  • CoQ10 is complementary (different mito target)
  • Exercise amplifies mitochondrial biogenesis from SS-31
  • Monitor cardiac markers if history of heart disease
Storage & Handling
  • Lyophilized: refrigerate at 2–8°C (36–46°F)
  • Reconstituted: refrigerate, use within 21 days
  • Protect from light
  • Do not freeze reconstituted solution
  • Tetrapeptide — relatively stable
Agent Verdict

The most clinically advanced mitochondrial therapy — and it's still investigational.

SS-31 has something most longevity peptides lack: Phase 3 clinical trial data. The cardiolipin-binding mechanism is elegant, the 5,000x mitochondrial concentration is unmatched, and the clinical results in heart failure are promising. For longevity purposes, SS-31 addresses the mitochondrial membrane deterioration that drives cellular energy decline with age. Stack with MOTS-C (AMPK activation) and Epithalon (telomere protection) for the complete Anti-Aging Stack. The daily injection protocol requires commitment, but mitochondrial function is the foundation everything else — cognition, energy, recovery, longevity — depends on.

Go Deeper
SS-31 protocol.

Our free Protocol Guide includes the complete Anti-Aging Stack — SS-31, MOTS-C, Epithalon with cardiac monitoring, mitochondrial biomarkers, and tracking templates.

43 peptide profiles
7 protocol templates
Blood work ranges
Free forever
Free 50-page Protocol Guide
38 peptides · 7 protocols · dosing tables · blood work reference
38+
Peptides
7
Protocols
50
Pages
Free Instant Access
Unlock your protocols.
Research-backed peptide guides, dosing calculators, and weekly intel — used by biohackers worldwide.
50-Page Protocol Guide PDF
38 peptides, 7 protocol templates, dosing tables, blood work reference
The Protocol Brief Weekly
Weekly research breakdowns, protocol spotlights, blood work insights
Select at least one option
Enter your first name
Enter a valid email

You're in.

No spam, ever. Unsubscribe anytime.